It is known that, in metabolic syndrome, the activity of angiogenesis processes in CA may be reduced, despite the increased expression of VEGF, which is associated with an altered VEGF signaling pathway—VEGF/VEGFR signaling [27]. The gene discussed is KDR; the disease is metabolic syndrome.